LG

Landegren Gene Technology

Europe, Uppsala Lan, Sweden, Uppsala

Description

Landegren Gene Technology

Investor Profile

Landegren Gene Technology has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Sweden.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Series A (100%)

Country Focus

  • Sweden (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Landegren Gene Technology frequently co-invest with?

N
Europe, Uppsala Lan, Sweden, Uppsala
Co-Investments: 1
BV
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Segulah Medical Acceleration
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1

What are some of recent deals done by Landegren Gene Technology?

Navinci Diagnostics

Uppsala, Uppsala Lan, Sweden

Navinci Diagnostics is a company that develops proprietary technology for detecting and quantifying proteins, protein interactions.

BiotechnologyHealth CareHealth Diagnostics
Series AJul 12, 2022
Amount Raised: $8,503,995